SCHEMBL25864323

SCHEMBL25864323

C=C(c1ccc(-c2nnc(NC3CC(C)(OC)C3)c3ccccc23)c(O)c1)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.42
IL1B P01584 8/20 0.38
TNF P01375 2/20 0.38
KCNH2 Q12809 1/20 0.33
CHEK1 O14757 1/20 0.32
CHEK2 O96017 1/20 0.32
KDM4E B2RXH2 2/20 0.32
HSD17B10 Q99714 2/20 0.32
KDR P35968 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
USP2 O75604 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25855817 0.90 NLRP3 (0.51) NLRP3IL1BTNFKCNH2CHEK1
SCHEMBL25864316 0.90 NLRP3 (0.40) NLRP3IL1BTNFKCNH2CHEK1
SCHEMBL25864320 0.89 NLRP3 (0.39) NLRP3IL1BTNFCHEK1CHEK2
SCHEMBL25864319 0.88 NLRP3 (0.38) NLRP3IL1BTNFCHEK1CHEK2
SCHEMBL25864318 0.88 NLRP3 (0.38) NLRP3IL1BTNFCHEK1CHEK2
SCHEMBL25864317 0.88 NLRP3 (0.38) NLRP3IL1BTNFCHEK1CHEK2
SCHEMBL25864324 0.87 NLRP3 (0.38) NLRP3IL1BTNFCHEK1CHEK2
SCHEMBL25864321 0.86 NLRP3 (0.37) NLRP3IL1BTNFCHEK2KDM4E
SCHEMBL25864322 0.86 NLRP3 (0.37) NLRP3IL1BTNFCHEK2KDM4E
SCHEMBL25864411 0.86 NLRP3 (0.40) NLRP3IL1BTNFKCNH2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131277-A1 NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF 药捷安康(南京)科技股份有限公司 2023-07-13 WO disclosed